| Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human … P Puligujja, JE McMillan, L Kendrick, T Li, S Balkundi, N Smith, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (8), 1263-1273, 2013 | 97 | 2013 |
| Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy N Gautam, U Roy, S Balkundi, P Puligujja, D Guo, N Smith, XM Liu, ... Antimicrobial agents and chemotherapy 57 (7), 3110-3120, 2013 | 75 | 2013 |
| Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations P Puligujja, SS Balkundi, LM Kendrick, HM Baldridge, JR Hilaire, ... Biomaterials 41, 141-150, 2015 | 72 | 2015 |
| Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes BJ Edagwa, D Guo, P Puligujja, H Chen, JE McMillan, X Liu, ... The FASEB journal 28 (12), 5071, 2014 | 49 | 2014 |
| Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals T Zhou, Z Lin, P Puligujja, D Palandri, J Hilaire, M Araínga, N Smith, ... Nanomedicine 13 (8), 871-885, 2018 | 27 | 2018 |
| Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice P Puligujja, M Araínga, P Dash, D Palandri, RL Mosley, S Gorantla, ... Antiviral research 120, 85-88, 2015 | 27 | 2015 |
| Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations N Gautam, P Puligujja, S Balkundi, R Thakare, XM Liu, HS Fox, ... Antimicrobial agents and chemotherapy 58 (12), 7510-7519, 2014 | 27 | 2014 |
| Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy T Li, HE Gendelman, G Zhang, P Puligujja, JEM McMillan, TK Bronich, ... International journal of nanomedicine, 3779-3790, 2015 | 24 | 2015 |
| Cellular responses and tissue depots for nanoformulated antiretroviral therapy AL Martinez-Skinner, MA Araínga, P Puligujja, DL Palandri, HM Baldridge, ... PLoS One 10 (12), e0145966, 2015 | 14 | 2015 |
| Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution D Guo, T Li, JE McMillan, BR Sajja, P Puligujja, MD Boska, ... Nanomedicine 9 (9), 1341-1352, 2014 | 14 | 2014 |
| Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes (vol 28, pg 5071, 2014) BJ Edagwa, D Guo, P Puligujja, H Chen, JE McMillan, X Liu, ... FASEB JOURNAL 31 (3), 1248-1248, 2017 | | 2017 |
| Cell-Targeted Antiretroviral Nanoformulations: Translational Studies in Mice P Puligujja University of Nebraska Medical Center, 2015 | | 2015 |
| Cell-Targeted Long-Acting Nanoformulated Antiretroviral Therapy P Puligujja, R Veerubhotla, JE McMillan, H Gendelman, X Liu JOURNAL OF NEUROVIROLOGY 18, 88-88, 2012 | | 2012 |
| N-formyl-methionine-leucine-phenylalanine (fMLP) Coated Nanoart P Puligujja, J Meyer, J McMillan, HE Gendelman, X Liu JOURNAL OF NEUROIMMUNE PHARMACOLOGY 7, S50-S50, 2012 | | 2012 |
| Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. M Araínga, P Puligujja, HM Baldridge | | |
Shantanu BalkundiLicensing Associate, Florida International UniversityVerified email at fiu.edu
